Biotechnology Jobs

Isomorphic Labs · Cambridge, United States

Lead the safety assessment strategy for small molecule and biologic drug discovery projects from inception to regulatory submission, designing screening cascades and mechanistic experiments. Partner with machine learning researchers to build predictive toxicology models and manage CRO relationships for outsourced wet-lab data generation, while mentoring junior team members.

Isomorphic Labs · London

Contribute to the design of novel large-molecule therapeutics by applying computational and machine learning methods to predict biologics properties such as affinity, developability and immunogenicity from sequence. Work within an interdisciplinary computational sciences team alongside ML and biologics discovery experts, benchmarking models, analysing lab data and shaping data-generation strategies for active learning.

GSK · Stevenage · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

GSK · Zug, Switzerland · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.

Pfizer · Cambridge, United States · US$176,600 – US$294,300 pa

Leads global evidence generation and health economics and outcomes research for a rare disease therapy, designing HEOR studies, economic models and value dossiers to support reimbursement and patient access. Works within a cross-functional matrix team and with country teams, guiding clinical trial design and payer-facing evidence strategy.

Pfizer · Collegeville, United States · US$176,600 – US$294,300 pa

Leads the global evidence generation strategy for a rare disease therapy, overseeing HEOR studies such as network meta-analyses, economic models, and non-interventional research from concept to publication. Partners with cross-functional teams and country affiliates to develop value dossiers and patient-reported outcome strategies that support reimbursement and market access. The role sits within Pfizer's HV&E team and involves managing external research collaborations and vendor relationships.

Newton Colmore · Spain

Bridge process biology and advanced sensing by running suspension CHO/HEK293 cultures from bench to pilot scale, building Raman/PLS chemometric models, and translating bioreactor behaviour into requirements for engineering and software teams. Work in a multidisciplinary group developing AI-driven bioprocessing systems for mammalian cell culture and monoclonal antibody production, with direct access to the CEO and CTO.

CSL · Opfikon, Switzerland

Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence, and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.

CSL · Maidenhead

Leads an integrated quality assurance organisation covering Good Clinical Practice and Good Pharmacovigilance Practice, reporting to the Head of Global R&D Quality. Sets strategy, operating model and standards for risk-based QA oversight from trial design through close-out, including clinical safety interfaces, inspection readiness and CAPA frameworks. Hybrid role with global scope and international travel.

Recursion · Remote Opportunity - United Kingdom · £136,500 – £167,200 pa

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead for regulatory interactions and study design from Phase 1-3. Perform and oversee modeling and simulation with tools such as WinNonlin, Monolix, NONMEM and R, and author regulatory sections for IBs, INDs and NDAs. Part of a Pharmacometrics team spanning clinical pharmacology, pharmacometrics and translational modeling, working end-to-end across discovery and development.

Recursion · Salt Lake City, United States · US$200,000 – US$220,500 pa

Lead a team of computational biologists in early discovery, acting as a player-coach who balances hands-on analysis with mentorship. Integrate phenomics, transcriptomics, genomics and proteomics data to nominate oncology and immunology targets, define validation criteria and precision medicine strategies, partnering with biologists, engineers and translational experts.

AstraZeneca · London

Finance lead for a designated disease area with full P&L ownership across UK & Ireland in-line and pipeline assets. Drives strategic planning, budgeting, monthly forecasting and pricing/reimbursement business cases, applying AI and advanced analytics, while partnering Commercial, Medical, Market Access and Global Finance. Office-based in London with at least 60% attendance.

Newton Colmore · Cambridge

Lead the design and development of next-generation drug delivery devices, guiding multidisciplinary teams of engineers, scientists and designers from early-stage concepts through to manufacturable solutions. The role blends hands-on R&D work — concept generation, prototyping, experimental design, verification planning and risk management — with client-facing consultancy, programme leadership and mentoring of junior colleagues.

Moderna · London

Leads CMC regulatory strategy for global submissions including IND, CTA, BLA and MAA, and oversees agency correspondence and compliance for mRNA products. Reviews submissions for readiness, drives health authority interactions, and advises manufacturing and quality teams on change controls and regulatory guidance across vaccines, oncology and rare disease programmes.

Moderna · Oxford

Provides scientific and hands-on leadership for immunogenicity and ligand binding assay bioanalysis supporting mRNA-LNP therapeutic programs, spanning assay development, validation, clinical sample testing and regulatory submissions. Ensures GcLP compliance and partners with cross-functional teams, with opportunities to work alongside data and AI-enabled analytical approaches.